MEI Pharma Inc Capital Reinvestment Ratio

Latest as of December 2020: 0.01x

MEI Pharma Inc capital reinvestment ratio. MEI Pharma Inc (MEIP) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow ($4.05 Million) in capital expenditures ($56.00K). Check how aggressively does MEI Pharma Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

Data as of

Dec 2020
Most recent filing

Capital Reinvestment Ratio of MEI Pharma Inc (2017–2020)

Capital reinvestment ratio of MEI Pharma Inc from 2017 to 2020. This chart tracks MEI Pharma Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore MEI Pharma Inc net asset momentum to track the company's year-over-year net asset growth rate.

MEI Pharma Inc Capital Reinvestment Ratio by Year (2017–2020)

MEI Pharma Inc capital reinvestment ratio by year from 2017 to 2020. For the full cash flow conversion analysis, see MEIP cash generation efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.03x $34.26 Million $894.00K ▲ +78.4%
2017 0.01x $3.49 Million $51.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow